National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

pegylated granulocyte colony stimulating factor MAXY-G34
A long-acting, pegylated recombinant variant of human granulocyte colony-stimulating factor (G-CSF) with immunomodulating activity. Pegylated granulocyte colony stimulating factor MAXY-G34 contains multiple non-naturally occurring lysines that have been introduced into alpha helixes of wild type human G-CSF as pegylation sites; other naturally occurring lysine residues have been removed to prevent pegylation and the variant G-CSF is pegylated with methoxypolyethylene glycol succinimidyl propionate (mPEG SPA) at three amino acid residues. Similar to endogenous G-CSF, this agent binds to and activates specific cell surface receptors, stimulating neutrophil progenitor proliferation and differentiation and selected neutrophil functions. A difference in the degree of pegylation may account for the extended half-life of this agent compared to pegfilgrastim which is pegylated at only one amino acid residue. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Abbreviation:PEG-CSF MAXY-G34
Code name:MAXY-G34



Previous:PEG-Intron, pegaspargase, PEGASYS, pegfilgrastim, pegylated anti-GFR antibody fragment
Next:pegylated interferon alfa, pegylated irinotecan NKTR 102, pegylated liposomal doxorubicin hydrochloride, pelitrexol, pemetrexed disodium

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov